Ms. Wendell has served as a member of the Board of Directors of Axogen, Inc. since September 2016 and was appointed Lead Director in May 2018. She was a senior advisor for the healthcare investment banking practice of Perella Weinber Partners (“PWP”) from January 2016 through April 2019. Her scope of responsibilities involves providing guidance and advice with respect to mergers and acquisitions and divestitures for clients and assisting PWP in connection with firm-level transactions. From 2015 through October 2018, Ms. Wendell was a senior advisor for McKinsey’s transactions advisory board to help define trends in mergers and acquisitions, as well as help shape McKinsey’s knowledge agenda. From 1986 until January 2015, Amy held various roles of increasing responsibility at Covidien plc (including its predecessors, Tyco Healthcare and Kendall Healthcare Products), including engineering, product management and business development. Most recently, from December 2006 until Covidien’s acquisition by Medtronic plc in January 2015, she served as senior vice president of strategy and business development, where she led the company’s strategy and portfolio management initiatives and managed all business development, including acquisitions, equity investments, divestitures and she Is a member of the board of directors of Hologic. She is also a director of Por Cristo, a nonprofit charitable medical service organization involved in health care work for at-risk women and children in Latin America. Amy holds a Bachelor of Science degree in mechanical engineering from Lawrence Technological University and a Master of Science degree in biomedical engineering from the University of Illinois.